sorafenib has been researched along with glycolipids in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (glycolipids) | Trials (glycolipids) | Recent Studies (post-2010) (glycolipids) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 19,062 | 170 | 5,050 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, J; Le, W; Li, M; Lu, H; Yuan, Y; Zhang, T; Zhou, L; Zuo, H | 1 |
1 other study(ies) available for sorafenib and glycolipids
| Article | Year |
|---|---|
Overriding sorafenib resistance via blocking lipid metabolism and Ras by sphingomyelin synthase 1 inhibition in hepatocellular carcinoma.
Topics: Adult; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Ceramides; Drug Resistance, Neoplasm; Humans; Lipid Metabolism; Liver Neoplasms; Membrane Proteins; Nerve Tissue Proteins; ras Proteins; Sorafenib; Sphingomyelins; Transferases (Other Substituted Phosphate Groups); Up-Regulation | 2021 |